266 related articles for article (PubMed ID: 17994454)
21. Differences between original intravenous iron sucrose and iron sucrose similar preparations.
Toblli JE; Cao G; Oliveri L; Angerosa M
Arzneimittelforschung; 2009; 59(4):176-90. PubMed ID: 19517894
[TBL] [Abstract][Full Text] [Related]
22. Comparison of oxidative stress markers after intravenous administration of iron dextran, sodium ferric gluconate, and iron sucrose in patients undergoing hemodialysis.
Pai AB; Boyd AV; McQuade CR; Harford A; Norenberg JP; Zager PG
Pharmacotherapy; 2007 Mar; 27(3):343-50. PubMed ID: 17316146
[TBL] [Abstract][Full Text] [Related]
23. Intravenous iron supplementation in children on hemodialysis.
Leijn E; Monnens LA; Cornelissen EA
J Nephrol; 2004; 17(3):423-6. PubMed ID: 15365964
[TBL] [Abstract][Full Text] [Related]
24. [Multi-frequency low-dose intravenous iron on oxidative stress in maintenance hemodialysis patients].
Yin L; Chen X; Chen J; Cheng M; Peng Y; Yang L
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2012 Aug; 37(8):844-8. PubMed ID: 22954919
[TBL] [Abstract][Full Text] [Related]
25. Effect of intravenous iron supplementation on hepatic cytochrome P450 3A4 activity in hemodialysis patients: a prospective, open-label study.
Pai AB; Norenberg J; Boyd A; Raj D; Chan LN
Clin Ther; 2007 Dec; 29(12):2699-705. PubMed ID: 18201586
[TBL] [Abstract][Full Text] [Related]
26. Oxidative stress: correlation with Behçet's disease duration, activity and severity.
Harzallah O; Kerkeni A; Baati T; Mahjoub S
Eur J Intern Med; 2008 Nov; 19(7):541-7. PubMed ID: 19013385
[TBL] [Abstract][Full Text] [Related]
27. Effect of vitamin E therapy on oxidative stress and erythrocyte osmotic fragility in patients on peritoneal dialysis and hemodialysis.
Uzum A; Toprak O; Gumustas MK; Ciftci S; Sen S
J Nephrol; 2006; 19(6):739-45. PubMed ID: 17173246
[TBL] [Abstract][Full Text] [Related]
28. Effects of garlic consumption on plasma and erythrocyte antioxidant parameters in elderly subjects.
Avci A; Atli T; Ergüder IB; Varli M; Devrim E; Aras S; Durak I
Gerontology; 2008; 54(3):173-6. PubMed ID: 18463427
[TBL] [Abstract][Full Text] [Related]
29. Enhanced oxidative stress in haemodialysis patients receiving intravenous iron therapy.
Lim PS; Wei YH; Yu YL; Kho B
Nephrol Dial Transplant; 1999 Nov; 14(11):2680-7. PubMed ID: 10534512
[TBL] [Abstract][Full Text] [Related]
30. Non-transferrin bound iron, cytokine activation and intracellular reactive oxygen species generation in hemodialysis patients receiving intravenous iron dextran or iron sucrose.
Pai AB; Conner T; McQuade CR; Olp J; Hicks P
Biometals; 2011 Aug; 24(4):603-13. PubMed ID: 21229380
[TBL] [Abstract][Full Text] [Related]
31. Oxidative stress in patients undergoing high-dose chemotherapy plus peripheral blood stem cell transplantation.
Cetin T; Arpaci F; Yilmaz MI; Saglam K; Ozturk B; Komurcu S; Gunay M; Ozet A; Akay C; Kilic S; Ulutin C
Biol Trace Elem Res; 2004 Mar; 97(3):237-47. PubMed ID: 14997024
[TBL] [Abstract][Full Text] [Related]
32. Influence of oxidative stress and inflammation on rHuEPO requirements of hemodialysis patients with CRP values "in normal range".
Tutal E; Sezer S; Bilgic A; Aldemir D; Turkoglu S; Demirel O; Ozdemir N; Haberal M
Transplant Proc; 2007 Dec; 39(10):3035-40. PubMed ID: 18089316
[TBL] [Abstract][Full Text] [Related]
33. Assessment of plasma antioxidant status in hemodialysis patients.
Kadkhodaee M; Hemmati M; Zahmatkesh M; Ghaznavi R; Mirershadi F; Mahdavi-Mazde M; Seifi B
Ther Apher Dial; 2008 Apr; 12(2):147-51. PubMed ID: 18387164
[TBL] [Abstract][Full Text] [Related]
34. Oxidative stress in half and full Ironman triathletes.
Knez WL; Jenkins DG; Coombes JS
Med Sci Sports Exerc; 2007 Feb; 39(2):283-8. PubMed ID: 17277592
[TBL] [Abstract][Full Text] [Related]
35. Serum selenium and plasma malondialdehyde levels and antioxidant enzyme activities in patients with obsessive-compulsive disorder.
Ozdemir E; Cetinkaya S; Ersan S; Kucukosman S; Ersan EE
Prog Neuropsychopharmacol Biol Psychiatry; 2009 Feb; 33(1):62-5. PubMed ID: 18957313
[TBL] [Abstract][Full Text] [Related]
36. Erythrocyte transmembrane electron transfer in haemodialysis patients.
Matteucci E; Cupisti A; Caprioli R; Battipaglia E; Favilla S; Rindi P; Barsotti G; Giampietro O
Nutr Metab Cardiovasc Dis; 2007 May; 17(4):288-93. PubMed ID: 17434051
[TBL] [Abstract][Full Text] [Related]
37. Administration of intravenous iron sucrose as a 2-minute push to CKD patients: a prospective evaluation of 2,297 injections.
Macdougall IC; Roche A
Am J Kidney Dis; 2005 Aug; 46(2):283-9. PubMed ID: 16112047
[TBL] [Abstract][Full Text] [Related]
38. Malondialdehyde and antioxidant enzymes in children with obstructive adenotonsillar hypertrophy.
Doğruer ZN; Unal M; Eskandari G; Pata YS; Akbaş Y; Cevik T; Cimen MY
Clin Biochem; 2004 Aug; 37(8):718-21. PubMed ID: 15302619
[TBL] [Abstract][Full Text] [Related]
39. [Does plasmapheresis affect the production of free radicals and the antioxidant system?].
Eiselt J; Racek J; Holecek V; Opatrný K
Cas Lek Cesk; 1996 Sep; 135(17):558-62. PubMed ID: 8964072
[TBL] [Abstract][Full Text] [Related]
40. Lipid peroxidation level and antioxidant enzyme activities in the blood of patients with acute and chronic fascioliasis.
Kaya S; Sütçü R; Cetin ES; Aridogan BC; Delibaş N; Demirci M
Int J Infect Dis; 2007 May; 11(3):251-5. PubMed ID: 16859944
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
